Paul Bieniasz
#95,586
Most Influential Person Now
British virologist whose main area of research is HIV/AIDS
Paul Bieniasz's AcademicInfluence.com Rankings
Paul Bieniaszbiology Degrees
Biology
#4953
World Rank
#7308
Historical Rank
Virology
#121
World Rank
#125
Historical Rank
Download Badge
Biology
Why Is Paul Bieniasz Influential?
(Suggest an Edit or Addition)According to Wikipedia, Paul Darren Bieniasz is a British-American virologist whose main area of research is HIV/AIDS. He is currently a professor of retrovirology at the Rockefeller University. He received the 2015 KT Jeang Retrovirology Prize and the 2010 Eli Lilly and Company Research Award. Bieniasz has been a Howard Hughes Medical Institute investigator since 2008.
Paul Bieniasz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu (2008) (1848)
- Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals (2020) (1577)
- Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry (2007) (1282)
- Corrigendum: A diverse range of gene products are effectors of the type I interferon antiviral response (2015) (1037)
- A diverse array of gene products are effectors of the type I interferon antiviral response (2011) (930)
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants (2020) (915)
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) (831)
- HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress (2001) (741)
- Evolution of antibody immunity to SARS-CoV-2 (2021) (703)
- Evolution of Antibody Immunity to SARS-CoV-2 (2020) (680)
- mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021) (621)
- Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells (2009) (578)
- Vaccine Breakthrough Infections with SARS-CoV-2 Variants (2021) (520)
- HIV therapy by a combination of broadly neutralizing antibodies in humanized mice (2012) (493)
- Intrinsic immunity: a front-line defense against viral attack (2004) (484)
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection (2021) (471)
- HIV Restriction Factors and Mechanisms of Evasion. (2012) (468)
- MX2 is an interferon-induced inhibitor of HIV-1 infection (2013) (432)
- Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. (2009) (426)
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies (2020) (418)
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants (2020) (417)
- Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins (2003) (407)
- Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors (2003) (403)
- Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin (2008) (399)
- Late budding domains and host proteins in enveloped virus release. (2006) (396)
- Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies (2020) (394)
- Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. (2004) (390)
- Nef proteins from simian immunodeficiency viruses are tetherin antagonists. (2009) (361)
- Plasma Membrane Is the Site of Productive HIV-1 Particle Assembly (2006) (361)
- Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses (2020) (351)
- Species-Specific Activity of HIV-1 Vpu and Positive Selection of Tetherin Transmembrane Domain Variants (2009) (321)
- Imaging the biogenesis of individual HIV-1 virions in live cells (2008) (315)
- HIV-1 Vpu Promotes Release and Prevents Endocytosis of Nascent Retrovirus Particles from the Plasma Membrane (2006) (311)
- Enhanced SARS-CoV-2 neutralization by dimeric IgA (2020) (301)
- Reconstitution of an Infectious Human Endogenous Retrovirus (2007) (297)
- Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism (2002) (294)
- APOBEC3G Incorporation into Human Immunodeficiency Virus Type 1 Particles (2004) (292)
- Plasma Neutralization of the SARS-CoV-2 Omicron Variant (2021) (292)
- An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. (2007) (292)
- CG-dinucleotide suppression enables antiviral defense targeting non-self RNA (2017) (277)
- Natural Variation in Vif: Differential Impact on APOBEC3G/3F and a Potential Role in HIV-1 Diversification (2005) (275)
- Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor (1997) (265)
- Role of ESCRT-I in Retroviral Budding (2003) (263)
- Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses (2020) (262)
- Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles (2009) (261)
- Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV‐1 Tat (1998) (261)
- Human Tripartite Motif 5α Domains Responsible for Retrovirus Restriction Activity and Specificity (2005) (258)
- The cell biology of HIV-1 virion genesis. (2009) (242)
- Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies (2021) (239)
- Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo (2020) (236)
- Restriction of multiple divergent retroviruses by Lv1 and Ref1 (2003) (233)
- HIV‐1‐induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR‐5 co‐receptor (1997) (227)
- Dynamics of ESCRT protein recruitment during retroviral assembly (2011) (217)
- Global Changes in the RNA Binding Specificity of HIV-1 Gag Regulate Virion Genesis (2014) (215)
- Cyclophilin Interactions with Incoming Human Immunodeficiency Virus Type 1 Capsids with Opposing Effects on Infectivity in Human Cells (2005) (212)
- HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway (2005) (211)
- Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species (2008) (199)
- Multiple Blocks to Human Immunodeficiency Virus Type 1 Replication in Rodent Cells (2000) (191)
- Analysis of the Initiating Events in HIV-1 Particle Assembly and Genome Packaging (2010) (184)
- Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination (2021) (183)
- Identification of Interferon-Stimulated Genes with Antiretroviral Activity (2016) (180)
- Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. (1999) (174)
- Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations (2021) (170)
- Human foamy virus reverse transcription that occurs late in the viral replication cycle (1997) (169)
- Generation of Simian-Tropic HIV-1 by Restriction Factor Evasion (2006) (166)
- Restriction of Human Immunodeficiency Virus Type 1 by TRIM-CypA Occurs with Rapid Kinetics and Independently of Cytoplasmic Bodies, Ubiquitin, and Proteasome Activity (2005) (163)
- A macaque model of HIV-1 infection (2009) (163)
- High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape (2021) (159)
- Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals (2020) (148)
- Human immunodeficiency virus, restriction factors, and interferon. (2009) (148)
- The RING-CH Ligase K5 Antagonizes Restriction of KSHV and HIV-1 Particle Release by Mediating Ubiquitin-Dependent Endosomal Degradation of Tetherin (2010) (146)
- Context-Dependent Effects of L Domains and Ubiquitination on Viral Budding (2004) (144)
- Host and Viral Determinants of Mx2 Antiretroviral Activity (2014) (141)
- Antiretroviral potential of human tripartite motif-5 and related proteins. (2006) (134)
- Longitudinal analysis of serology and neutralizing antibody levels in COVID19 convalescents. (2020) (128)
- Species-Specific Tropism Determinants in the Human Immunodeficiency Virus Type 1 Capsid (2004) (127)
- Restriction factors: a defense against retroviral infection. (2003) (126)
- A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation (2015) (125)
- Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients (2020) (123)
- Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo (2011) (122)
- A role for ubiquitin ligases and Spartin/SPG20 in lipid droplet turnover (2009) (118)
- Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. (2006) (117)
- Vpu Binds Directly to Tetherin and Displaces It from Nascent Virions (2013) (113)
- Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients (2020) (113)
- Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost (2022) (110)
- Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants (2021) (109)
- Envelope-Dependent, Cyclophilin-Independent Effects of Glycosaminoglycans on Human Immunodeficiency Virus Type 1 Attachment and Infection (2002) (109)
- Integration target site selection by a resurrected human endogenous retrovirus. (2009) (108)
- Intrinsic cellular defenses against human immunodeficiency viruses. (2012) (106)
- Mechanism of HIV-1 Virion Entrapment by Tetherin (2013) (106)
- Extreme genetic fragility of the HIV-1 capsid (2013) (105)
- Properties of human foamy virus relevant to its development as a vector for gene therapy. (1999) (105)
- Structural insight into the mechanisms of enveloped virus tethering by tetherin (2010) (102)
- Hypermutation of an Ancient Human Retrovirus by APOBEC3G (2008) (100)
- HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis (2016) (99)
- Temporal and spatial organization of ESCRT protein recruitment during HIV-1 budding (2014) (96)
- Cell cycle dependence of foamy retrovirus infection (1995) (96)
- Human Immunodeficiency Virus Type 1 Matrix Inhibits and Confers Cooperativity on Gag Precursor-Membrane Interactions (2004) (95)
- Determination of RNA structural diversity and its role in HIV-1 RNA splicing (2020) (93)
- Fates of Retroviral Core Components during Unrestricted and TRIM5-Restricted Infection (2013) (90)
- HIV/AIDS: in search of an animal model. (2007) (90)
- Extreme Genetic Fragility of the HIV-1 Capsid (2013) (87)
- Identification of Human VPS37C, a Component of Endosomal Sorting Complex Required for Transport-I Important for Viral Budding* (2005) (85)
- Structure of the zinc-finger antiviral protein in complex with RNA reveals a mechanism for selective targeting of CG-rich viral sequences (2019) (85)
- A comparative study of higher primate foamy viruses, including a new virus from a gorilla. (1995) (84)
- Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1 (1993) (84)
- Ubiquitin-dependent virus particle budding without viral protein ubiquitination (2007) (81)
- Multiple Residues Contribute to the Inability of Murine CCR-5 To Function as a Coreceptor for Macrophage-Tropic Human Immunodeficiency Virus Type 1 Isolates (1998) (77)
- Visualizing HIV-1 assembly. (2011) (76)
- SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release (2011) (76)
- Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2 (2018) (76)
- Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice (2021) (75)
- HIV-1–induced AIDS in monkeys (2014) (75)
- Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation (1997) (74)
- Plasma neutralization properties of the SARS-CoV-2 Omicron variant (2021) (72)
- Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents (2020) (70)
- Chemokine receptors and human immunodeficiency virus infection. (1998) (68)
- Single-Cell and Single-Cycle Analysis of HIV-1 Replication (2015) (67)
- Co-option of an endogenous retrovirus envelope for host defense in hominid ancestors (2017) (67)
- Functional Interchangeability of Late Domains, Late Domain Cofactors and Ubiquitin in Viral Budding (2010) (63)
- No evidence of antibody to human foamy virus in widespread human populations. (1996) (61)
- A Bipartite Late-Budding Domain in Human Immunodeficiency Virus Type 1 (2003) (61)
- Inhibition of HIV-1 particle assembly by 2',3'-cyclic-nucleotide 3'-phosphodiesterase. (2012) (61)
- Sequences in pol Are Required for Transfer of Human Foamy Virus-Based Vectors (1998) (59)
- B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV (2021) (57)
- Isolation of a new foamy retrovirus from orangutans (1994) (53)
- Clathrin Facilitates the Morphogenesis of Retrovirus Particles (2011) (53)
- Tetherin Promotes the Innate and Adaptive Cell–Mediated Immune Response against Retrovirus Infection In Vivo (2014) (51)
- Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins (2022) (50)
- Primate Lentivirus Capsid Sensitivity to TRIM5 Proteins (2008) (49)
- Capsid-Dependent and -Independent Postentry Restriction of Primate Lentivirus Tropism in Rodent Cells (2004) (48)
- Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins. (2014) (47)
- Analysis of the human immunodeficiency virus-1 RNA packageome (2016) (46)
- Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity (2020) (45)
- Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies (2021) (45)
- The RNA Binding Specificity of Human APOBEC3 Proteins Resembles That of HIV-1 Nucleocapsid (2016) (44)
- Identification of Domains in Gag Important for Prototypic Foamy Virus Egress (2005) (44)
- Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients (2020) (42)
- APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA (2017) (42)
- Effect of DNA Repair Protein Rad18 on Viral Infection (2006) (42)
- Gene transfer using replication-defective human foamy virus vectors. (1997) (42)
- Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection (2020) (40)
- Evidence for Restriction of Ancient Primate Gammaretroviruses by APOBEC3 but Not TRIM5α Proteins (2008) (40)
- Serological Analysis of New York City COVID19 Convalescent Plasma Donors (2020) (40)
- No effect of endogenous TRIM5α on HIV-1 production (2008) (39)
- Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies (2021) (38)
- Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies (2021) (38)
- Highly Divergent Lentiviral Tat Proteins Activate Viral Gene Expression by a Common Mechanism (1999) (38)
- Predictors of Nonseroconversion after SARS-CoV-2 Infection (2021) (38)
- Multiple, Switchable Protein:RNA Interactions Regulate Human Immunodeficiency Virus Type 1 Assembly. (2018) (37)
- Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV‐1‐infected individuals (1993) (37)
- The Betaretrovirus Mason-Pfizer Monkey Virus Selectively Excludes Simian APOBEC3G from Virion Particles (2006) (35)
- Convergent antibody responses to SARS-CoV-2 in convalescent individuals (2020) (35)
- Analysis of the Effect of Natural Sequence Variation in Tat and in Cyclin T on the Formation and RNA Binding Properties of Tat-Cyclin T Complexes (1999) (35)
- Antiretroviral restriction factors. (2011) (35)
- Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro (2020) (35)
- Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection (2020) (34)
- Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20 (2018) (34)
- Assisted Evolution Enables HIV-1 to Overcome a High TRIM5α-Imposed Genetic Barrier to Rhesus Macaque Tropism (2013) (34)
- Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies (2021) (33)
- Adaptation to the Interferon-Induced Antiviral State by Human and Simian Immunodeficiency Viruses (2013) (33)
- Identification of a receptor for an extinct virus (2010) (33)
- Global synonymous mutagenesis identifies cis-acting RNA elements that regulate HIV-1 splicing and replication (2018) (32)
- Increased Potency and Breadth of SARS-CoV-2 Neutralizing Antibodies After a Third mRNA Vaccine Dose (2022) (32)
- Identification of HIV-1 subtype G from Uganda. (1995) (32)
- Matrix-Induced Inhibition of Membrane Binding Contributes to Human Immunodeficiency Virus Type 1 Particle Assembly Defects in Murine Cells (2005) (30)
- Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo (2020) (30)
- HIV-1 at 25 (2008) (29)
- Role of chemokine receptors in HIV-1 infection and pathogenesis. (1999) (29)
- Functional Differences between Human and Bovine Immunodeficiency Virus Tat Transcription Factors (2000) (28)
- Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape (2021) (28)
- Replication and single-cycle delivery of SARS-CoV-2 replicons (2021) (28)
- Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations (2021) (27)
- Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity. (2011) (27)
- Origins and Evolution of tetherin, an Orphan Antiviral Gene. (2016) (25)
- Murine CXCR-4 is a functional coreceptor for T-cell-tropic and dual-tropic strains of human immunodeficiency virus type 1 (1997) (24)
- HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137 (2019) (24)
- Specific binding of recombinant foamy virus envelope protein to host cells correlates with susceptibility to infection. (1999) (23)
- Uneven Genetic Robustness of HIV-1 Integrase (2014) (23)
- An overview of intracellular interactions between immunodeficiency viruses and their hosts (2012) (23)
- VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA (2020) (22)
- The aryl hydrocarbon receptor and interferon gamma generate antiviral states via transcriptional repression (2018) (22)
- A single gp120 residue can affect HIV-1 tropism in macaques (2017) (22)
- Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans (2022) (21)
- Cyclin T1 Expression Is Mediated by a Complex and Constitutively Active Promoter and Does Not Limit Human Immunodeficiency Virus Type 1 Tat Function in Unstimulated Primary Lymphocytes (2002) (20)
- Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency (2020) (19)
- Genome-Wide Analysis of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) Binding to HIV-1 RNA Reveals a Key Role for hnRNP H1 in Alternative Viral mRNA Splicing (2019) (18)
- Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State (2019) (18)
- The case against delaying SARS-CoV-2 mRNA vaccine boosting doses (2021) (17)
- Vaccination boosts naturally enhanced neutralizing breadth to SARS-CoV-2 one year after infection (2021) (17)
- Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins (2022) (16)
- Origin and evolution of the zinc finger antiviral protein (2020) (16)
- Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes (2019) (14)
- Naturally enhanced neutralizing breadth to SARS-CoV-2 after one year. (2021) (14)
- HIV-1 matrix-tRNA complex structure reveals basis for host control of Gag localization. (2021) (14)
- High genetic barrier to escape from human polyclonal SARS-CoV-2 neutralizing antibodies (2021) (13)
- Tetherin Inhibits Cell-Free Virus Dissemination and Retards Murine Leukemia Virus Pathogenesis (2017) (12)
- Early treatment with a combination of two potent neutralizing antibodies improves clinical outcomes and reduces virus replication and lung inflammation in SARS-CoV-2 infected macaques (2021) (12)
- Multimeric nanobodies from camelid engineered mice and llamas potently neutralize SARS-CoV-2 variants (2021) (12)
- Analysis of HIV-1 Gag-RNA Interactions in Cells and Virions by CLIP-seq. (2016) (12)
- An intrinsic host defense against HIV-1 integration? (2007) (11)
- Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination (2022) (11)
- CLIP-related methodologies and their application to retrovirology (2018) (11)
- HIV clearance in an infant? (1995) (11)
- HIV Replication in CD4-Negative Cell Lines: Effect of Cloning, CD4 Expression and Inhibition by Dextrin Sulphate (1993) (10)
- A facile quantitative assay for viral particle genesis reveals cooperativity in virion assembly and saturation of an antiviral protein. (2012) (10)
- Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity (2021) (10)
- Poly(ADP-ribose) potentiates ZAP antiviral activity (2020) (10)
- Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2 (2021) (10)
- Therapeutic Neutralizing Monoclonal Antibodies: Report of a Summit sponsored by Operation Warp Speed and the National Institutes of Health (2020) (9)
- Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens (2022) (9)
- Derivation of simian tropic HIV-1 infectious clone reveals virus adaptation to a new host (2019) (9)
- Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection (2022) (8)
- Molecular fate-mapping of serum antibody responses to repeat immunization (2023) (8)
- Mechanisms of Attenuation by Genetic Recoding of Viruses (2021) (8)
- Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape (2022) (8)
- Inhibition of spumavirus gene expression by PHF11 (2020) (7)
- Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans (2022) (7)
- Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population (2022) (7)
- Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins (2022) (7)
- The Case Against Delaying Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine Boosting Doses (2021) (7)
- Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection (2019) (6)
- Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination (2022) (6)
- Rational attenuation of RNA viruses with zinc finger antiviral protein (2022) (6)
- An Interferon- α -Induced Tethering Mechanism Inhibits HIV-1 and Ebola Virus Particle Release but Is Counteracted by the HIV-1 Vpu Protein Cell Host Microbe. (2013) (6)
- Reconstruction of a replication-competent ancestral murine endogenous retrovirus-L (2018) (6)
- Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis (2022) (6)
- “A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.” (2020) (5)
- VPS29 Exerts Opposing Effects on Endocytic Viral Entry (2021) (5)
- Molecular mechanism of desensitization of the chemokine receptor CCR‐5: receptor signaling and internalization are dissociable from its role as an HIV‐1 co‐receptor (2013) (4)
- Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies (2021) (4)
- Development of a rapid quantitative assay for HIV‐1 plasma infectious viraemia‐culture‐PCR (CPID) (1994) (4)
- Derivation and characterization of an HIV-1 mutant that rescues IP6 binding deficiency (2021) (4)
- Bispecific antibody neutralizes circulating SARS-CoV-2 variants, prevents escape and protects mice from disease (2021) (3)
- Repurposing a Bacterial Immune System to Discover Antiviral Targets (2017) (3)
- Molecular modelling predicts SARS-CoV-2 ORF8 protein and human complement Factor 1 catalytic domain sharing common binding site on complement C3b (2020) (3)
- A multimodal antiretroviral protein (2018) (3)
- Molecular mechanism of desensitization of the chemokine receptor CCR5 : receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor important in acute inflammatory responses (2013) (3)
- Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection (2022) (3)
- Bispecific antibody prevents SARS-CoV-2 escape and protects mice from disease (2021) (3)
- Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain (2022) (3)
- Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteins (2022) (2)
- Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants (2022) (2)
- SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection (2022) (2)
- Identification of claudin-1 as an essential cellular cell entry factor for hepatitis C virus (2006) (2)
- Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting (2021) (2)
- Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population (2022) (2)
- Sensing retroviruses. (2011) (1)
- A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in Macaques. (2021) (1)
- Human anti-ACE2 monoclonal antibodies as pan-sarbecovirus prophylactic agents (2022) (1)
- Molecular fate-mapping of serum antibodies reveals the effects of antigenic imprinting on repeated immunization (2022) (1)
- Resource Identification of Interferon-Stimulated Genes with Antiretroviral Activity Graphical (2016) (1)
- Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland (2021) (1)
- Author response: Nuclear pore heterogeneity influences HIV-1 infection and the antiviral activity of MX2 (2018) (1)
- Author response: Co-option of an endogenous retrovirus envelope for host defense in hominid ancestors (2017) (0)
- Human Tripartite Motif 5 (cid:2) Domains Responsible for Retrovirus Restriction Activity and Specificity (2005) (0)
- CLIP-related methodologies and their application to retrovirology (2018) (0)
- The Betaretrovirus Mason-Pfizer Monkey Virus Selectively Excludes Simian APOBEC3G from Virion Particles (cid:1) (2006) (0)
- 1 Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from 2 individuals with recent seasonal coronavirus infection 3 (2020) (0)
- Reconstruction of a replication-competent ancestral murine endogenous retrovirus-L (2018) (0)
- Host Resistance to Retroviruses (2008) (0)
- Initiation of HIV-1 Gag lattice assembly is required for recognition of the viral genome packaging signal (2023) (0)
- Correction for Bitzegeio et al., Adaptation to the Interferon-Induced Antiviral State by Human and Simian Immunodeficiency Viruses (2015) (0)
- 155 Tetherin, an interferon-alpha induced inhibitor of retrovirus release that is antagonized by Vpu (2009) (0)
- Derivation and characterization of an HIV-1 mutant that rescues IP6 binding deficiency (2021) (0)
- Faculty Opinions recommendation of Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. (2006) (0)
- The KT Jeang Retrovirology prize 2015 (2015) (0)
- Transcriptional regulation of epithelial- mesenchymal transition (2007) (0)
- Convalescent Plasma-Mediated Resolution of Covid-19 in Humoral Immunodeficiency (2020) (0)
- Author response: Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape (2021) (0)
- In Brief (2008) (0)
- HIV/Ebola comparison could spur new treatments. (2002) (0)
- Correction: Plasma Membrane Is the Site of Productive HIV-1 Particle Assembly (2018) (0)
- Publisher Correction: Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice (2021) (0)
- Crystal Structure of macaque APOBEC3H in complex with RNA (2017) (0)
- Retrovirus Infection In Vivo Mediated Immune Response against - Cell Tetherin Promotes the Innate and Adaptive (2014) (0)
- 689. Restriction Profiles of Primate TRIM5α on FIV (2006) (0)
- Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape (2023) (0)
- KHNYN is a zinc-finger antiviral protein (ZAP) co-factor that degrades ZAP-bound RNA (2022) (0)
- PS1-122 Unraveling the complexity of the type I interferon antiviral response (2011) (0)
- The application of clustered regularly interspaced short palindromic repeats genome engineering to the study of host antiviral factors (VIR9P.1160) (2015) (0)
- Derivation and Characterization of an inositol phosphate-independent HIV-1 (2021) (0)
- Structural basis for host tRNA control of HIV-1 Gag localization (2022) (0)
- Author response: Rhabdo-immunodeficiency virus, a murine model of acute HIV-1 infection (2019) (0)
- The Role of Diverse VPU Proteins in Human Immunodeficiency Virus Type 1 (HIV-1) Viral Particle Release (2007) (0)
- Initiation of HIV-1 Gag lattice assembly is required for cytoplasmic recognition of the viral genome packaging signal (2022) (0)
- Opening the HIV Mystery Box (2014) (0)
- Determination of RNA structural diversity and its role in HIV-1 RNA splicing (2020) (0)
- APOBEC3H structure reveals an unusual mechanism of interaction with duplex RNA (2017) (0)
- 135 Tetherin - Keeping Virions on a Leash (2012) (0)
- Antiretroviral Activity Host and Viral Determinants of Mx 2 (2014) (0)
- Short Communication: Ultrasensitive Immunoassay for Assessing Residual Simian-Tropic HIV in Nonhuman Primate Models of AIDS. (2019) (0)
- A multimodal antiretroviral protein (2018) (0)
- Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain (2023) (0)
This paper list is powered by the following services:
Other Resources About Paul Bieniasz
What Schools Are Affiliated With Paul Bieniasz?
Paul Bieniasz is affiliated with the following schools:
